RIVN enters September under pressure — the stock fell 7.2% on the week to $15.54, short interest has quietly rebuilt over the past month, and the next earnings print is eight weeks away.
The short interest story is the one to watch. Bears control 12.6% of the free float — a level ORTEX classifies as high — and that position has grown nearly 8% over the past month. The weekly tick-up of 1.3% is modest on its own, but the one-month trajectory tells a more deliberate story: shorts added steadily through August as the stock briefly recovered from July lows. At 154 million shares short, the position is now close to its recent peak from mid-August. The FINRA fortnightly data puts days-to-cover at 9.03, meaning it would take shorts over nine trading sessions to unwind at current volumes — a meaningful overhang. Importantly, borrowing costs remain extremely cheap at 0.53%, and borrow availability at 253% is well above the tight threshold, meaning there is no friction pushing bears toward the exit. The ORTEX short score has held in the mid-60s all week, ranking in just the 7th percentile for short score across the universe — positioning looks structurally bearish, not opportunistically so.
Options positioning is notably calm given the price action. The put/call ratio of 0.92 is essentially flat against its 20-day average of 0.92, with a z-score near zero. That neutrality is telling: despite a 7% weekly drop, options traders are not piling into downside protection. The 52-week PCR range runs from 0.78 to 1.21, so the current reading sits comfortably in the middle. There is no panic hedge in the options market, which either reflects confidence that the dip is temporary or — more likely — that the options market had already priced in a cautious bias toward this name. RIVN fell 6.8% the day after its July earnings report, and dropped a further 5.8% over the following five days. The next print is scheduled for October 27, and that July reaction is fresh context for anyone holding through it.
The Street is broadly constructive but with important dissent. After the July 30 earnings, multiple analysts lifted price targets simultaneously — RBC moved to $16 from $14, TD Cowen to $21 from $20, Wells Fargo to $16 from $15, and Needham reiterated its $23 Buy. Piper Sandler upgraded to Overweight ahead of results with a $20 target. The outlier is Morgan Stanley, which kept its Underweight rating and raised its target only to $14 — still below the current price. The bull case centres on R2 and R3 platform launches, Amazon fleet economics, and improving unit margins. Bears point to deeply negative EBITDA (EV/EBITDA of -16.7x), persistent cash burn, and a competitive consumer EV market. EPS momentum factor scores rank in just the 9th-to-11th percentile, flagging that forward estimate revisions remain negative despite the operational progress narrative.
Ownership adds texture to the picture. Volkswagen subsidiary Porsche Automobil Holding holds 14.5% of shares (as last disclosed in May 2026, under a passive Schedule 13G/A), up from 12.3% previously. Amazon holds a stable 10.9%. Slate Path Capital and Uber Technologies both appear as new or significantly enlarged positions in the June 30 13F data, with Uber holding roughly 19.6 million shares — a strategically interesting position given the two companies' autonomous and fleet vehicle discussions. Baillie Gifford, once a top holder, filed a 13G/A in early 2025 disclosing a stake just below the 5% threshold. D.E. Shaw and Two Sigma both grew positions substantially in Q2, adding a quantitative-strategy bid to the holder base. Insider data from EDGAR is stale (last filed January 2026), so no fresh read on management sentiment is available. CEO Robert Scaringe's sales from January were all executed under a 10b5-1 plan and carry limited directional signal.
With the stock down 7% on the week while LCID fell 13.5% and XPEV dropped 3.7%, RIVN is holding up relative to the weaker end of its EV peer group — though TSLA managed a 1.7% gain over the same period. What to watch next is whether the short rebuild continues into October or stalls ahead of the earnings date: a sustained move back above $17 would start to pressure a position where the cost of staying short is currently negligible, but the borrow pool is deep enough that no mechanical squeeze is imminent.
See the live data behind this article on ORTEX.
Open RIVN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
